powered by:
yole développement

Slider home

Thermo Fisher Scientific announces its ion PGM Dx next generation sequencing system is now CE-marked for in Vitro Diagnostic (IVD) use

Thermo Fisher Scientific announced the successful CE-IVD registration of its new Ion PGM Dx System for sale in European countries. The Ion PGM Dx System was developed using the proven Ion Torrent next generation sequencing (NGS) technology, currently used to produce hundreds of thousands of tests in clinical research laboratories each year to uncover meaningful genetic information for a range of human conditions.

Read more: Thermo Fisher Scientific announces its ion PGM Dx next generation sequencing system is now...

BD acquires GenCell Biosystems

Transaction advances BD’s entry into next generation sequencing market.

BD (Becton, Dickinson and Company), a leading global medical technology company, announced that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications.

Read more: BD acquires GenCell Biosystems

Illumina accelerator announces investment in inaugural startup class

Initial companies focused on breakthrough applications in therapeutics, agriculture, and molecular pathology.

Illumina, Inc. announced the selection of three startup companies for the inaugural Illumina Accelerator funding cycle.

Read more: Illumina accelerator announces investment in inaugural startup class

Medical imaging market: companies play a new game …

During the latest months, Yole Développement (Yole) identified numerous investments, mergers, acquisitions in the solid-state medical image sensors market. The research market and strategy consulting company confirms today, in its latest technology & market analysis, Solid State Medical Imaging: X-ray and Endoscopy, the direct impact on the supply chain. With 2.1 million units in 2013, medical imaging market is evolving slowly with related players that strongly compete more to get an access to the market, than to develop and acquire new technologies.

Read more: Medical imaging market: companies play a new game …

MNBS 2014: from R&D to innovation

8th Annual Concertation and Consultation Workshop on Micro-Nano-Bio Convergence Systems on October 21-22, 2014 in Toulouse. Yole Finance, the corporate finance services unit of Yole Développement (Yole) collaborates with the European Commission and the Laboratory for Analysis and Architecture of Systems (LAAS, Toulouse, France) to promote the smart systems technologies through the 8th Annual Concertation and Consultation Workshop on Micro-Nano-Bio Convergence Systems (MNBS 2014 – October 21 – 22, 2014).

Read more: MNBS 2014: from R&D to innovation

Steady growth and technology inflections open opportunities for medical image sensors

CMOS and emerging technologies will help drive sales of image sensors for x-ray equipment and endoscopes to $142 million by 2019.

Demand for image sensors for medical applications will see steady 11% growth, to pass the $142 million mark by 2019. The main growth driver is the increasing demand for medical treatment by an aging population in developed markets, and by growing wealth in emerging regions.

Read more: Steady growth and technology inflections open opportunities for medical image sensors

LATEST EVENTS

Tue Oct 07 @12:00AM
SEMICON EUROPA
Wed Oct 08 @12:00AM
SEMICON EUROPA
Thu Oct 09 @12:00AM
SEMICON EUROPA